跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 15,871 条关于
“Blue Owl Healthcare Opportunities”
全部
15,871
临床试验
3,991
药物
475
机构
509
资讯
10,896
11个月前
Ovid Therapeutics Secures $175M PIPE Financing to Advance CNS Drug Pipeline Through 2028
3年前
Novo Holdings Leads $200M Series A Investment in Windward Bio for Advanced Respiratory Treatments
去年
Aviceda Therapeutics Secures $207.5 Million to Advance Geographic Atrophy Treatment
去年
Windward Bio Launches with $200 Million to Advance Long-Acting Anti-TSLP Antibody for Asthma and COPD
去年
Windward Bio Secures Global License for Anti-TSLP Antibody SKB378/HBM9378 in $970M Deal
10个月前
Repare Therapeutics Agrees to $1.82 Per Share Acquisition by XenoTherapeutics
去年
Nuvig Therapeutics Secures $161 Million to Advance Novel Immunomodulatory Therapies
4个月前
Windward Bio Secures $165M to Advance Ultra Long-Acting Immunology Therapies for Asthma and COPD
2个月前
Chemomab and Scipher Medicine Merge to Advance Nebokitug in AI-Powered Phase 2 Rheumatoid Arthritis Trial
6个月前
Blue Jet Healthcare Announces ₹2,300 Crore Pharmaceutical Manufacturing Facility in Andhra Pradesh
第 1 页，共 1090 页
上一页
下一页
